Whom are we treating with lipid-lowering drugs? Are we following the guidelines? Evidence from a population-based study: the Tromso study 2001.
Hartz
Ingeborg
I
Institute of Pharmacy, University of Tromsø, 9037, Tromso, Norway. ingeborg@farmasi.uit.no
Eggen
Anne Elise
AE
Grimsgaard
Sameline
S
Skjold
Frode
F
Njølstad
Inger
I
D000328:Adult; D000367:Age Factors; D000368:Aged; D002784:Cholesterol / Q000097:blood; D003327:Coronary Disease / Q000453:epidemiology / Q000209:etiology / Q000517:prevention & control; D003430:Cross-Sectional Studies; D003920:Diabetes Mellitus / Q000453:epidemiology / Q000209:etiology / Q000517:prevention & control; D004363:Drug Utilization; D005260:Female; D006801:Humans; D006937:Hypercholesterolemia / Q000150:complications / Q000188:drug therapy* / Q000453:epidemiology; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D016015:Logistic Models; D008297:Male; D008875:Middle Aged; D009664:Norway / Q000453:epidemiology; D017410:Practice Guidelines as Topic; D012307:Risk Factors; D012737:Sex Factors; D011795:Surveys and Questionnaires
D000960:Hypolipidemic Agents; D002784:Cholesterol